We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Robotic Use Increases to Speed Lab Workflow

By LabMedica International staff writers
Posted on 28 Jun 2017
Print article
Image: Without robotics and automation, some labs may be unable to keep pace with testing, and the loss of experienced technicians (Photo courtesy of Lab Automation).
Image: Without robotics and automation, some labs may be unable to keep pace with testing, and the loss of experienced technicians (Photo courtesy of Lab Automation).
Robotic lab automation is making progress and removing some of the labor in laboratories, but rarely is it replacing all functions. Although the most common use of robots is partial, the number of laboratories using them is on the rise. Without robotics and other types of automation, laboratories may be unable to keep pace with testing, the complexities of new tests, such as those involving molecular diagnostics, and the loss of experienced technicians and technologists. These are the latest findings of Kalorama Information, (New York, NY, USA), an independent medical market research firm.

Currently, robotics are finding use in several laboratory processes, ranging from the capping and decapping of sample bottles to high throughput screening. However, one of the major constraints to market growth is the limited adoption of automation and robotics – 10% or less of automation – by small and medium-sized laboratories – those laboratories that process fewer than 100 tubes on a daily basis.

Going forward, much emphasis will be placed on modular robotic automation, which is extremely important for laboratories looking to speed their workflow to keep up with the increasing number of tests, including molecular tests. In order to establish themselves in the market place, robotic systems vendors need to increase productivity and efficiency at laboratories while also helping them to cut costs and errors, and improve productivity. To achieve this, robotics must prove itself as a solution that can address and optimize workflow and many of the phases involved in clinical diagnostics, such as sample collection and sample processing.

“Total lab automation may be appropriate for large-size laboratories, it is not suited for smaller laboratories. It can lead to an increase in the total cost of automation. Moreover, it gives many laboratories little option for future planning, especially if it turns out they do not need to have extensively automated,” said Joe Constance, the author of the study. “Investing in laboratory automation systems is an expensive proposition, and may not be affordable to small and medium-sized laboratories, even if it is a one-time investment.”

Related Links:
Kalorama Information

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Signs of multiple sclerosis show up in blood years before symptoms appear (Photo courtesy of vitstudio/Shutterstock)

Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset

Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.